Pervaiz, Shazib
NUS Yong Loo Lin School of Medicine,
Singapore
2025 Rank: 67698
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1086 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67698 | 63411 |
| Total Cites | 1825 | 1986 |
| H-index | 12 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 45 | 49 |
| Number of Single+First+Last Authored Papers | 134 | 134 |
| Total Cites to Single+First+Last Authored Papers | 343 | 376 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1747 | 1866 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
8.11%
|
|
Pervaiz, Shazib
National University of Singapore,
Singapore
2024 Rank: 60599
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1082 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60599 | 55453 |
| Total Cites | 1616 | 1770 |
| H-index | 11 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 50 | 56 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 304 | 341 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1575 | 1681 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.05 |
| Self-Citation Percentage |
8.70%
|
|
Pervaiz, Shazib
NUS Yong Loo Lin School of Medicine,
Singapore
2023 Rank: 41951
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 844 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41951 | 48426 |
| Total Cites | 1474 | 1560 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 55 | 55 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 386 | 395 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1432 | 1510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
5.51%
|
|
Pervaiz, Shazib
NUS Yong Loo Lin School of Medicine,
Singapore
2022 Rank: 28172
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 677 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28172 | 29095 |
| Total Cites | 1394 | 1571 |
| H-index | 15 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 89 | 95 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 410 | 477 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1348 | 1453 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.08 |
| Self-Citation Percentage |
11.27%
|
|
Pervaiz, Shazib
National University of Singapore,
Singapore
2021 Rank: 30315
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 702 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30315 | 29538 |
| Total Cites | 1991 | 2312 |
| H-index | 17 | 17 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 34 | 35 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 122 | 144 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 563 | 674 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1903 | 2104 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.10 |
| Self-Citation Percentage |
13.88%
|
|
Pervaiz, Shazib
Yong Loo Lin School of Medicine,
Singapore
2020 Rank: 26779
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 530 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26779 | 24143 |
| Total Cites | 1893 | 2534 |
| H-index | 15 | 16 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 95 | 113 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 420 | 499 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1815 | 2327 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.09 |
| Self-Citation Percentage |
25.30%
|
|